Phosphatidic acid signaling to mTOR: Signals for the survival of human cancer cells
- 2 March 2009
- journal article
- research article
- Published by Elsevier
- Vol. 1791 (9) , 949-955
- https://doi.org/10.1016/j.bbalip.2009.02.009
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with RapamycinMolecular and Cellular Biology, 2009
- 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a Phospholipase D Pharmacological Inhibitor That Alters Cell Spreading and Inhibits ChemotaxisMolecular Pharmacology, 2009
- Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2Journal of Biological Chemistry, 2008
- Re-evaluating the Roles of Proposed Modulators of Mammalian Target of Rapamycin Complex 1 (mTORC1) SignalingJournal of Biological Chemistry, 2008
- Honokiol Suppresses Survival Signals Mediated by Ras-Dependent Phospholipase D Activity in Human Cancer CellsClinical Cancer Research, 2008
- Phospholipase D1 is an effector of Rheb in the mTOR pathwayProceedings of the National Academy of Sciences, 2008
- Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-RasCancer Letters, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AMLBlood, 2006
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005